These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Subscribe To Our Newsletter & Stay Updated